SymBiosis is an investment firm focused on advancing biotherapeutics innovations for serious and life-threatening diseases. The firm invests in groundbreaking medicines across disease area, financing stage, and geography, with a focus on programs in, or about to enter, human trials. SymBiosis currently manages a portfolio of more than 30 investments and has significant, long-term capital commitments to fund future investments. 

Biotechnology

Health Care

Life Sciences

Therapeutics

Venture Capital

SymBiosis

SymBiosis' headquarters in Bentonville, United States

��

People (6)

Jobs (0)

Other offices

��������

People (6)

Jobs (0)

Other offices

��